IthaID: 2966
Names and Sequences
| Functionality: | Globin gene causative mutation | Pathogenicity: | Pathogenic / Likely Pathogenic |
|---|---|---|---|
| Common Name: | CD 98/99 (+TG) | HGVS Name: | HBB:c.296_297dup |
| Hb Name: | Hb Patagonia | Protein Info: | β 99(+TG); modified C-terminal sequence |
Also known as:
Comments: Appears as de novo mutation, in heterozygote state, with severe thalassaemia-like features. Patient presented with haemolytic anaemia requiring multiple blood transfusions, followed by splenectomy. Predicted to cause frameshift resulting in an elongated β-globin and a modified C-terminal sequence. Structural characterization suggested alteration of the tertiary structure, as well as of the majority of the positions involved in αβ dimer formation.
We follow the HGVS sequence variant nomenclature and IUPAC standards.
Phenotype
| Hemoglobinopathy Group: | Structural Haemoglobinopathy |
|---|---|
| Hemoglobinopathy Subgroup: | β-chain variant |
| Allele Phenotype: | N/A |
| Stability: | Hyperunstable |
| Oxygen Affinity: | N/A |
| Associated Phenotypes: | N/A |
Location
| Chromosome: | 11 |
|---|---|
| Locus: | NG_000007.3 |
| Locus Location: | 71020 |
| Size: | 2 bp |
| Located at: | β |
| Specific Location: | Exon 2 |
Other details
| Type of Mutation: | Point-Mutation(Insertion) |
|---|---|
| Effect on Gene/Protein Function: | Frameshift (Translation) |
| Ethnic Origin: | Argentinean |
| Molecular mechanism: | Unstable T state |
| Inheritance: | Dominant |
| DNA Sequence Determined: | Yes |
In silico pathogenicity prediction
Publications / Origin
- Scheps KG, Hasenahuer MA, Parisi G, Fornasari MS, Pennesi SP, Erramouspe B, Basack FN, Veber ES, Aversa L, Elena G, Varela V, Hb Wilde and Hb Patagonia: two novel elongated beta-globin variants causing dominant beta-thalassemia., Eur. J. Haematol. , 94(6), 498-503, 2015
Created on 2016-08-23 14:53:33,
Last reviewed on 2022-01-28 12:42:28 (Show full history)
Disclaimer: The information on this website is provided as an information resource only
and must not to be used as a substitute for professional diagnosis and treatment.
The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment,
diagnosis or any other information, services or products that an individual obtains through this website.